By the combined use of DNase I footprinting, electrophoretic mobility-shift assay, and methylation interference analysis, we have identified a series of sequence-specific protein-DNA interactions in the 5' flanking region of the rat osteocalcin gene. Stimulation of osteocalcin gene expression by 1,25-dihydroxyvitamin D3, a physiologic mediator of this bonespecific gene in vitro and -in vivo, is associated with modifications in the binding of ROS 17/2.8 cell nuclear factors to two promoter segments that up-regulate transcription. One segment located between -462 and -437 exhibits a vitamin D-dependent increase in sequence-specific binding of nuclear factors. This element (CTGGGTGAATGAGGACATTACT-GACC), identified at single nucleotide resolution, contains a region of hyphenated dyad symmetry and shares sequence homology with consensus steroid-responsive elements and with the sequence that has been identified as the vitamin D receptor binding site in the human osteocalcin gene. We have also observed that vitamin D stimulation of osteocalcin gene expression results in a 5-fold increase in protein binding to the region of the osteocalcin box, a 24-nucleotide segment in the proximal promoter with a CCAAT motif as the central core. Our results demonstrate protein-DNA interactions in a vitamin D-responsive element and in a second sequence, the osteocalcin box, both of which are involved in the physiologic regulation of the osteocalcin gene in response to 1,25-dihydroxyvitamin D3.
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The osteocalcin gene encodes a 6-kDa polypeptide (1) (2) (3) (4) (5) that represents the most abundant noncollagenous protein of the bone matrix and the only known bone tissue-specific protein (reviewed in ref. 6 ). For the rat gene, the mRNA is transcribed from a 953-nucleotide segment of DNA containing 4 exons and 3 introns (2) (3) (4) (5) . The osteocalcin gene promoter has a modular organization reflected by the representation of RNA polymerase II canonical sequences and of a series of consensus sequences for hormone receptor binding sites and nucleotide-responsive elements, which are physiologic mediators of osteocalcin gene expression (2, 5) .
The calcitrophic hormone 1,25-dihydroxyvitamin D3
[1,25(OH)2D3] plays a key role in the transcriptional regulation of osteocalcin gene expression in osteoblasts both in vitro and in vivo (2) (3) (4) 7) . Thus, experimentally addressing the mechanisms by which transcription of the osteocalcin gene is modulated by vitamin D is necessary for understanding regulation at the biochemical as well as at the molecular level. Our previous studies (4) , and those of others (2, 3, 8) , were grown to confluence in F12 medium supplemented with 5% (vol/vol) fetal calf serum. The medium was then exchanged for fresh medium containing 10 nM 1,25(OH)2D3 in 0.1% ethanol, and after 24 hr of treatment nuclei were isolated and nuclear extracts were prepared according to the method of Dignam et al. (9) .
Probes and Competitor DNA Fragments. The probe for the proximal region of the osteocalcin promoter was the -141 to +39 fragment of the rat osteocalcin gene clone pOC3.4 (4). The osteocalcin box probe was the -99 to -76 sequence that includes the CCAAT box. The distal probe was the -527 to -344 fragment. For the competition experiments, a doublestranded oligonucleotide corresponding to sequences from -462 to -436, designated VDRE (vitamin D-responsive element) of the rat osteocalcin gene promoter, was synthesized. Competition experiments were also performed with sequences containing putative binding sites for general transcription factors; these oligonucleotides were derived from histone gene promoter DNA-protein interaction domains designated H3-site II (-148 to -122) and H4-site II (-91 to -64) and both include their respective CAAT box domains (10) (11) (12) . The oligonucleotide designated H4-site I spans nucleotides -152 to -128 of the histone H4 gene promoter and contains a putative cAMP binding site. The Spl oligonucleotide contains two high-affinity Spl binding sites (13) .
Abbreviations: 1,25-(OH)2D3, 1,25-dihydroxyvitamin D3; VDRE, vitamin D-responsive element.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. prominent band produced by nuclear extracts from the vitamin D-treated cells but was not observed with extracts from the untreated control cells. When the protein-DNA complex V was further examined at single nucleotide resolution by methylation interference analysis, as shown in Fig. 3B , the G residues that interfered with the binding of the vitamin D-induced proteins were localized within sequences of the osteocalcin gene promoter (-465 to -437) also protected against DNase I digestion (Fig. 2B) . These results confirmed the identification of the VDRE and the specificity of the observed protein-DNA interactions.
Sequence specificity ofprotein binding to the -527 to -344 fragment was additionally established by competition gel mobility-shift analyses. As indicated by the results in Fig. 3C only the -462 to -436 sequence, the putative VDRE based on a region of homology with the human osteocalcin VDRE and a region containing hyphenated dyad symmetry (see Fig.  1 ). No competition was observed using an Spl consensus sequence or an oligonucleotide for the site I human H4 histone gene proximal promoter element (11) , which contains a cAMP consensus sequence similar to that observed in the VDRE region of the osteocalcin gene (Fig. 1) . The vitamin D-induced protein-DNA interactions, which are revealed by footprint analyses and defined at single nucleotide resolution by methylation interference (summarized in Fig. 4 and C, were observed with both the control and vitamin D extracts; a selective 5-fold increase in representation of the A complex was associated with vitamin D-stimulated osteocalcin gene expression (Fig. 5B) . Methylation interference analyses ( Fig. SC) illustrates the multiple protein-DNA interactions formed in this proximal promoter region and reflects the complexity of regulation at this site.
Specificity ofthe observed protein-DNA interactions comprising the A, B, and C complexes associated with the osteocalcin box promoter elements is supported by results from competition gel mobility-shift analyses presented in Fig.  7 . Sequence-specific competition for formation of the three complexes occurred when the unlabeled probe was used as competitor. In contrast, oligonucleotides for the site II elements of H3 (10) and H4 (11) The single end-labeled HindIII/EcoRI fragment from pUC19, which contained the 24-base-pair osteocalcin box, was used as the probe. The same unlabeled fragment (50-fold, 150-fold, and 250-fold excess) was used as the OC box competitor (lanes [13] [14] [15] [16] . Other competitors used were H4 site II oligonucleotide (lanes 5-8) and H3 site II oligonucleotide (lanes 1-4), which contain the CAAT box regions of the human histone H4 and H3 genes and H4 site I oligonucleotide (lanes 9-12), which contains a putative cAMP binding site.
-85), a proximal regulatory element with a CCAAT motif as a central core.
The osteocalcin gene promoter exhibits a modular organization, with a complex series ofconsensus sequences bearing homology to response elements for several physiologic mediators of osteocalcin gene expression, including cAMP and estrogen, glucocorticoid, and thyroid hormone, in addition to 1,25(OH)2D3. From our results, it is evident that at least one of these putative elements and the osteocalcin box exhibit vitamin D-dependent changes in protein-DNA interactions. However, the role of the vitamin D-induced changes in the osteocalcin box region is not clear, since gene constructs containing only this segment of the promoter have been shown to be unresponsive to vitamin D induction (2, 3, 8) .
It remains to be established how the vitamin D-induced modifications in protein binding to both the regulatory elements of the osteocalcin gene are related, and how they individually or together contribute to the regulation of osteocalcin gene transcription. The observed changes in protein binding to these 5' regulatory elements (which occur in association with modifications in transcription) may represent newly synthesized proteins, recruitment of proteins, or modifications of DNA-associated polypeptides; all are possibilities for establishing control mechanisms. However, the enhancer-like activity of steroid responsive elements and the primary regulatory roles of CCAAT-containing elements may
